宏达高科(002144) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥128,542,967.33, representing a 19.39% increase compared to ¥107,664,130.42 in the same period last year[9] - Net profit attributable to shareholders was ¥23,957,264.79, a significant increase of 46.50% from ¥16,353,569.18 year-on-year[9] - Basic earnings per share rose to ¥0.14, up 55.56% from ¥0.09 in the same period last year[9] - The company reported a net profit attributable to shareholders of 23.96 million, a 46.50% increase from 16.35 million, due to improved internal management and sales growth[17] - Net profit for Q1 2021 reached CNY 24,041,645.30, compared to CNY 17,959,336.20 in the same period last year, representing a growth of approximately 33.3%[41] - Total comprehensive income for Q1 2021 was CNY 16,315,145.30, compared to CNY 3,794,086.20 in the same period last year[42] Cash Flow - The net cash flow from operating activities reached ¥7,474,078.48, marking a substantial increase of 155.99% compared to ¥2,919,683.37 in the previous year[9] - The net cash flow from operating activities was CNY 7,474,078.48, compared to CNY 2,919,683.37 in the previous year, indicating a significant improvement[49] - Cash inflow from investment activities reached CNY 257,989,665.28, a substantial increase from CNY 23,904,029.50 in the prior year[49] - The net cash flow from investment activities was CNY 50,578,946.18, recovering from a negative cash flow of CNY 11,481,047.19 in the same period last year[49] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,962,747,658.60, a slight increase of 0.77% from ¥1,947,784,415.31 at the end of the previous year[9] - Total current assets amounted to CNY 751,396,604.83, an increase of 3.1% from CNY 724,235,895.66 on December 31, 2020[31] - Total current liabilities increased to CNY 146,849,643.18, up from CNY 145,293,745.69, indicating a rise of 1.1%[33] - The total liabilities decreased slightly to CNY 178,954,271.99 from CNY 180,306,174.00, a reduction of 0.7%[33] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,559[13] - The largest shareholder, Shen Guofu, holds 22.71% of the shares, amounting to 40,150,081 shares[13] Expenses - Sales expenses rose by 40.92% from 2.92 million to 4.12 million, mainly due to increased business expansion and transportation costs[17] - R&D expenses increased by 31.05% from 3.83 million to 5.02 million, reflecting higher costs in the research phase[17] - Research and development expenses for Q1 2021 were CNY 5,022,852.48, compared to CNY 3,832,916.02 in the previous year, indicating a growth of approximately 30.9%[40] Investment Income - Investment income surged by 89.33% from 6.19 million to 11.72 million, driven by gains from the disposal of subsidiary equity and increased financial product returns[17] - Investment income for Q1 2021 was CNY 11,724,798.44, up from CNY 6,192,897.47 in the previous period[40] Other Financial Metrics - The weighted average return on equity was 1.35%, up from 0.95% in the previous year[9] - The company reported non-recurring gains and losses totaling ¥7,719,129.75 for the period[10] - Other comprehensive income after tax for Q1 2021 was CNY -7,726,500.00, an improvement from CNY -14,165,250.00 year-over-year[41] - The company’s operating profit was CNY 14,970,752.90, an increase from CNY 11,892,923.53 in the same quarter last year[45]